Navigation Links
EndoChoice(R) Launches CEU Program on Proper Endoscope Reprocessing and a Line of Flexible Endoscope Reprocessing Products
Date:3/18/2010

ALPHARETTA, Ga., March 18 /PRNewswire/ -- EndoChoice, Inc. strengthens its position as the leader in endoscopy industry with the launch of a new CEU program and a complete line of products focused on efficient and effective endoscope reprocessing.  "Incidents of pathogen transmission related to flexible endoscopy continue to be reported in the media, and ECRI Institute continues to receive reports of potential endoscopy-related cross-contamination in facilities around the United States," 2010 Top 10 Technology Hazards, Health Devices, Nov. 2009.

EndoChoice's new CEU Video Program for Endoscope Reprocessing educates physicians, nurses and technicians on the proper protocol for reprocessing endoscopes.  This unique program provides one contact hour of continuing education for the gastroenterology professional with an overview of the professional society guidelines for proper endoscope care and infection control.  Mark DeLegge, M.D., Director of the Digestive Disease Center at the Medical University of South Carolina, says, "Reprocessing is the most critical component of an endoscopy procedure," and, "A CEU program is an important training tool to encourage and support proper reprocessing."

EndoChoice recently launched a full line of best-in-class endoscope reprocessing products, designed to meet the established society guidelines for proper endoscope care and infection control.

Mark Gilreath, EndoChoice's CEO, said, "We understand the vital importance of proper infection control and the issues associated with effective endoscope reprocessing.  As a result, we have developed a CEU program and a complete line of GI specific reprocessing products to support the society guidelines.  We strive to be an advocate for the GI professional in everything we do, so we are very pleased to offer this educational program to the GI community."

About EndoChoice, Inc.

EndoChoice designs, manufactures and markets innovative solutions for professionals in gastrointestinal endoscopy worldwide.  Its diverse portfolio of high-quality equipment, devices, supplies and services has uniquely positioned EndoChoice as a leading GI resource.  The company strives to exceed its customers' expectations through its superior products, exemplary customer care, knowledgeable sales force, and easy online ordering.  For more information, visit www.endochoice.com.

SOURCE EndoChoice, Inc.

Back to top

RELATED LINKS
http://www.endochoice.com

'/>"/>

SOURCE EndoChoice, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences Ltd. ... specializing in the development of cannabinoid-based drugs, today ... company overview at three upcoming scientific and investor ... LD Micro Invitational: ... Date:                     ...
(Date:5/23/2017)... , May 23, 2017  Leaf Healthcare, ... innovative medical devices for pressure ulcer prevention, will ... American Association of Critical Care Nurses, National Teaching ... 22-25. The Leaf Patient Monitoring System ... for the hospital environment.  The system seamlessly tracks ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... Antoine Dental Center is now offering various types ... replacement and act as a support for prosthetic teeth, such as crowns, bridges, or dentures. ... and becomes a sturdy, lasting new root for the tooth. , Several types of ...
(Date:6/26/2017)... ... 26, 2017 , ... The Centers for Advanced Orthopaedics (The ... Richard Robinson as chief operating officer (COO). In this role, Robinson brings more ... record of simplifying business processes and developing growth strategies to increase market share. ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... Antonio, TX (PRWEB) , ... June 26, 2017 ... ... physicians, their coding staff, and consumers are seeing lots of red these days. ... receive contain inaccurate charges that result from medical coding errors(1). Some studies point ...
(Date:6/26/2017)... WI (PRWEB) , ... June 26, 2017 , ... New ... consultations from Dr. Angela Cotey, with or without a referral. Dr. Cotey is a ... benefits of this preferred tooth replacement option. , Patients with missing teeth in Fitchburg, ...
Breaking Medicine News(10 mins):